Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

NCT04389151 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Colon Cancer

Interventions

DRUG: Toripalimab

Sponsor

The First Affiliated Hospital of Xiamen University